Course of thyroid nodules

Experimental and Clinical Endocrinology and Diabetes

Volumn 106, Issue SUPPL. 4, 1998, Pages

  Hoermann, R ^a,b   Quadbeck, B ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Growth; Iodine; Levothyroxin; Therapy; Thyroid nodules

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; THYROTROPIN; THYROTROPIN RECEPTOR;

CELL PROLIFERATION; CONFERENCE PAPER; DISEASE COURSE; ECHOGRAPHY; GENE MUTATION; GERMANY; HUMAN; IODINE DEFICIENCY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYROID CELL; THYROID NODULE;

EID: 0031733459     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212052     Document Type: Conference Paper

References (33)

1. Blum M, Rothschild M: Improved nonoperative diagnosis of the solitary 'cold' thyroid nodule: surgical selection based on risk factors and three months of suppression. JAMA 243: 242-45, 1980
2. Burgi H, Supersaxo Z, Selz B: Iodine deficiency diseases in Switzerland one hundred years after Theodor Kocher's survey: a historical review with some new goitre prevalence data. Acta Endocrinol 123: 577-590, 1990
3. Burrow GN, Mujtaba Q, LiVolsi V, Cornog J: The incidence of carcinoma in solitary 'cold' thyroid nodules. Yale J Biol Med 51: 13-17, 1978
4. Celani MF, Mariani M, Mariani G: On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid thyroid nodules. Acta Endocrinol 123: 603-608, 1990
5. Cheung PSY, Lee JMH, Boey JH: Thyroxine suppressive therapy for benign solitary thyroid nodules: a prospective randomized study. World J of Surg 13: 818-822, 1989
6. Derwahl M: Molekulare Aspekte in der Pathogenese von Knoten und Adenomen der Schiddrüse. Schweiz Med Wochenschr 124: 1613-1618, 1994
7. Derwahl M, Hamacher C, Russo D, Bröcker M, Manole M, Schatz H, Kopp P, Filetti S:. Constitutive activation of the Gsα protein adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas. J Clin Endocrinol Metab 81: 1898-1904, 1996
8. Derwahl M: Editorial: TSH-receptor and Gs-α gene mutations in the pathogenesis of toxic thyroid adenomas - note of caution. J Clin Endocrinol Metab 81: 2783-2785, 1996
9. Derwahl M: Von der diffusen Struma zur Knotenstruma. Internist 39: 577-583, 1998
10. Di Carlo A, Mariano A, Pisano G, Parmeggiani U, Beguinot L, Macchia V: Epidermal growth factor and thyrotropin response in human thyroid tissues. J Endocrinol Invest 13: 293-299, 1990
11. Dumont JE, Lamy F, Roger P, Maenhaut C: Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 72: 667-697, 1992
12. Fey MF, Peter HJ, Hinds HL et al.: Clonal analysis of human tumors with M27 beta, highly informative polymorphic X chromosomal probe. J Clin Invest 89: 1438-1444, 1992
13. Getaz EP, Shimaoka K, Razack M, Friedman M, Rao U. Suppressive therapy for postirradiation thyroid nodules. Can J Surg 23: 558-562, 1980
14. Gharib H, James EM, Charboneau JW, Naessens JM, Offord KP, Gorman CA: Suppressive therapy with Levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 317(2): 70-75, 1987
15. Hampel R, Kühlberg T, Klein K, Jerichow JU, Pichmann EG, Clausen V, Schmidt I: Strumaprävalenz in Deutschland größer als bisher angenommen. Med Klinik 90: 342-349, 1995
16. Hermus AR, Huysmans DA: Treatment of benign nodular thyroid disease. N Engl J Med 338: 1438-1447, 1998
17. Kopp P, Kimura ET, Aeschimann S et al.: Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters. J Clin Endocrinol Metab 79: 134-139, 1994
18. Kuma K, Matsuzuka F, Kobayashi A, Hirai K, Morita S, Miyauchi A, Katayama S, Sugawara M: Outcome of long standing solitary thyroid nodules. World J Surg 16: 583-588, 1992
19. Kuma K, Matsuzuka F, Yokozawa T, Miyauchi A, Sugawara M: Fate of untreated benign thyroid nodules: Results of long-term follow-up. World J Surg 18: 495-499, 1994
20. Lima N, Knobel M, Cavaliere H, Sztejnsznajd C, Tomimori E, Medeiros-Neto G: Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 7: 691-697, 1997
21. Mainini E, Martinelli I, Morandi G, Villa S, Stefani I, Mazzi C: Levothyroxine suppressive therapy for solitary thyroid nodules. J Endocrinol Invest 18: 797-799, 1995
22. Maciel RM, Moses AC, Villone G, Tramontano D, Ingbar SH: Demonstration of the production and physiological role of insulin-like growth factor II in rat thyroid follicular cells in culture. J Clin Invest 82:1546-1553, 1988
23. Minuto F, Barreca A, Del Monte P, Cariola G, Torre GC, Giordano G: Immunoreactive insulin-like growth factor I (IGF-1) and IGF-binding protein content in human thyroid tissue. J Clin Endocrinol Metab 68: 621-626, 1989
24. Papini E, Petrucci L, Guglielmi R, Panunzi C, Rinaldi R, Bacci V, Crescenzi A, Nardi F, Fabbrini R, Pacella CM: Long-term changes in nodular goiter: A 5-year prospective randomized trial of Levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 83: 780-783, 1998
25. Papini E, Bacci V, Panunzi C, Pacella CM, Fabbrini R, Bizzarri G, Petrucci L, Giammarco V, LaMedica P, Masala M, Pitaro M, Nardi F: A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules. Clin Endocrinol 38: 507-513, 1993
26. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G: Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649-651, 1993
27. Parma J, Duprez L, Van Sande J, Paschke R, Tonacchera M, Dumont J, Vassart G: Constitutively active receptors as a disease-causing mechanism. Mol Cell Endocrinol 100:159-162, 1994
28. Paschke R, Ludgate M: The thyrotropin receptor in thyroid diseases. N Engl J Med 337: 1675-1681, 1997
29. Peter HJ, Gerber H, Studer H, Smeds S: Pathogenesis of heterogeneity in human multinodular goiter. A study on growth and function of thyroid tissue transplantated onto nude mice. J Clin Invest 76: 1992-2002, 1985
30. Quadbeck B, Prüllage J, Mann K, Hoermann R: Long-term course of thyroid nodules in euthyroid goiter. Exp Clin Endocrinol 106 (Suppl. 1): 61, 1998 (Abstract)
31. Reverter JL, Lucas A, Salinas I, Audi L, Foz M, Sanmarti A. Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol 36: 25-28, 1992
32. Studer H, Derwahl M: Mechanisms of nonneoplastic endocrine hyperplasia ñ a changing concept: a review focused on the thyroid gland. Endocr Rev 16: 411-426, 1995
33. Thomas GA, Williams D, Williams ED: Clonal origin of thyroid tumours. In: Wynford-Thomas D, Williams ED (eds) Thyroid Tumours. Churchill Livingstone, London 123: 1673-1681, 1989